Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy

Schumacher, Martin C; Burkhard, Fiona C; Thalmann, George N; Fleischmann, Achim; Studer, Urs E (2008). Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. European urology, 54(2), pp. 344-52. Amsterdam: Elsevier 10.1016/j.eururo.2008.05.023

[img] Text
1-s2.0-S030228380800626X-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (650kB)

BACKGROUND: Conflicting results exist regarding the value of an extended pelvic lymph node dissection (PLND) in node-positive patients undergoing radical retropubic prostatectomy (RRP) for clinically localized prostate cancer. OBJECTIVE: To assess the long-term outcome in node-positive patients who underwent extended PLND followed by RRP. DESIGN, SETTING, AND PARTICIPANTS: A consecutive series of 122 node positive patients with negative preoperative staging examinations, no neoadjuvant hormonal or radiotherapy, and who underwent extended PLND (>/=10 lymph nodes in the surgical specimen) followed by RRP were analyzed. None of the patients received immediate androgen deprivation therapy (ADT). INTERVENTION: All patients underwent extended PLND followed by RRP. MEASUREMENTS: Biochemical recurrence-free survival, cancer-specific, and overall survival were assessed using the Kaplan-Meier technique. RESULTS AND LIMITATIONS: Median prostate-specific antigen (PSA) was 16ng/ml. At pathological examination 76% of the 122 patients had pT3-pT4 tumours, 50% seminal vesicle infiltration. A median of 22 nodes were removed per patient. Median cancer-specific survival at 5 and 10 yr was 84.5% and 60.1%, respectively. In patients with </=2 or >/=3 positive nodes removed, median cancer-specific survival at 10 yr was 78.6% and 33.4%, respectively (p<0.001). After a median period of 33 mo, 61 of the 122 patients (50%) received ADT, particularly those (69%) with >/=3 positive nodes removed. This retrospective study includes a significant percentage of patients with high tumour burden, and therefore may not reflect current patient series. CONCLUSIONS: Patients with </=2 positive nodes detected after extended PLND followed by RRP had good long-term results and should not be denied treatment with curative intent. In contrast, prognosis was poor in patients with >/=3 positive nodes, despite extended PLND and despite ADT in 69% of patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Burkhard, Fiona Christine, Thalmann, George, Fleischmann, Achim, Studer, Urs

ISSN:

0302-2838

ISBN:

18511183

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:02

Last Modified:

05 Jul 2023 14:28

Publisher DOI:

10.1016/j.eururo.2008.05.023

PubMed ID:

18511183

Web of Science ID:

000258251300016

BORIS DOI:

10.48350/27141

URI:

https://boris.unibe.ch/id/eprint/27141 (FactScience: 104452)

Actions (login required)

Edit item Edit item
Provide Feedback